Kodiak Sciences reports Phase 3 wins for Zenkuda and tabirafusp-ted, outlines BLA timelinesNov 12Quarterly update4D Molecular TherapeuticsKodiak Sciences Inc
Kodiak's Zenkuda and tabirafusp-ted hit primary endpoints in Phase 3 DAYBREAK trialSep 28Clinical readout4D Molecular TherapeuticsKodiak Sciences Inc
Kodiak reports Q2 2026 results, confirms three Phase 3 readouts by year-endAug 13Quarterly updateKodiak Sciences Inc
Kodiak Sciences recruiting Phase 3 ALTO trial testing tabirafusp tedromer vs. aflibercept in DMEJul 29Trial updateafliberceptKodiak Sciences Inc